A Relapsing Immune Thrombocytopenia Case in a Patient Following COVID-19 Vaccination

Abstract

There are several vaccines developed against COVID-19 infection. Inactivated viral vaccines are usually well tolerated. We aimed to present a relapsing immune thrombocytopenia case following inactive COVID-19 vaccine. Here we report a case of relapsing immune thrombocytopenia following inactivated viral vaccine against COVID-19 in a 60-year-old woman with a history of immune thrombocytopenia. The patient responded well to dexamethasone treatment and was discharged from the hospital with full recovery. We suggest that physicians seek the history of a recent inactivate COVID-19 vaccine shot in patients with immune thrombocytopenia.

Keywords

COVID-19 - immune thrombocytopenia - inactivated viral vaccine

• References

• 1 Flaxman S, Mishra S, Gandy A. et al Imperial College COVID-19 Response Team. Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe. Nature 2020; 584 (7820) 257-261
• 2 Aktas G, Altinordu R, Mercan Z, Savli H. Immune thrombocytopenia; following seasonal flu vaccine and nonsteroidal anti-inflamatory drug use. Prof Med J 2016; 23: 630-633
• 3 Woods Jr VL, Oh EH, Mason D, McMillan R. Autoantibodies against the platelet glycoprotein IIb/IIIa complex in patients with chronic ITP. Blood 1984; 63 (02) 368-375
• 4 Fogarty P, Minichiello T. Disorders of hemostasis, thrombosis, and antithrombotic therapy. In: Papadakis MA, McPhee SJ, eds. Current Medical Diagnosis and Treatment. 54th ed. New York, NY: McGraw Hill Lange Publication 2015: 536-561
• 5 Peltola H, Heinonen OP, Valle M. et al The elimination of indigenous measles, mumps, and rubella from Finland by a 12-year, two-dose vaccination program. N Engl J Med 1994; 331 (21) 1397-1402
• 6 Meyboom RH, Fucik H, Edwards IR. Thrombocytopenia reported in association with hepatitis B and A vaccines. Lancet 1995; 345 (8965) 1638
• 7 Schattner A. Consequence or coincidence? The occurrence, pathogenesis and significance of autoimmune manifestations after viral vaccines. Vaccine 2005; 23 (30) 3876-3886